DanielCChungMD

Associate Professor of Medicine, Harvard Medical School

Dr. Chung is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
55 Fruit St
BLK 4
Boston, MA 02114
Phone+1 617-724-6004

Fax+1 617-724-5996

Genetic Testing Decision Aid Start of enrollment: 2022 Oct 14
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Development and Implementation of Electronic Decision Aids for Genetic Testing in Inherited Cancer Syndromes Start of enrollment: 2020 Nov 20
Completed
Not Applicable
Roles: Principal Investigator, Contact

PubMed

967 citations
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3...
Stephen R. Russell, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Zi Fan Yu
Lancet. 2017-08-26
304 citations
AAV2 Gene Therapy Readministration in Three Adults with Congenital Blindness
Jean Bennett, Manzar Ashtari, Jennifer Wellman, Kathleen A. Marshall, Laura Cyckowski
Science Translational Medicine. 2012-02-08
25 citations
A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2).
Ahmad Yazdani, Daniel C. Chung, Mohammad Reza Abbaszadegan, Kholoud Al-Khayer, Wai-Man Chan
American Journal of Ophthalmology. 2003-11-01